Literature DB >> 1913650

Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions.

E A McLellan1, A Medline, R P Bird.   

Abstract

The main objective of the present study was to sequentially analyze growth and morphological characteristics of aberrant crypt foci (ACF) in the rat colon. Sprague-Dawley rats were given a single injection of a carcinogenic dose of 1,2-dimethylhydrazine-HCl and at varying time points ranging from 2 to 57 weeks, groups of 5 rats were terminated. The number and crypt multiplicity of ACF were determined in the distal 8 cm of the colon. In addition, ACF were processed for histology and then graded for the presence of nuclear atypia using a score of 0-4. The findings of the present study demonstrated that ACF exhibit the characteristics expected for precursor lesions. ACF were present at all time intervals in large numbers in the colons of rats treated with 1,2-dimethylhydrazine-HCl and were present when adenocarcinomas were observed. The number of ACF with 4 or more crypts and those exhibiting a higher grade (grade 4) of nuclear atypia increased significantly at or beyond 19 weeks. These features of ACF, particularly the presence of nuclear atypia indicative of dysplasia, provide strong support for the hypothesis that ACF are precursor lesions of chemically induced colon cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913650

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Identification of dysplasia in human colonic aberrant crypt foci.

Authors:  I M Siu; T G Pretlow; S B Amini; T P Pretlow
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

3.  Arsenic trioxide exposure accelerates colon preneoplasic aberrant crypt foci induction regionally through mitochondrial dysfunction.

Authors:  Hichem Moulahoum; Belkacem Mohamed Amine Boumaza; Meriem Ferrat; Bahia Djerdjouri
Journal:  Toxicol Res (Camb)       Date:  2017-09-27       Impact factor: 3.524

4.  Does senna extract promote growth of aberrant crypt foci and malignant tumors in rat colon?

Authors:  N Mascolo; E Mereto; F Borrelli; P Orsi; D Sini; A A Izzo; B Massa; M Boggio; F Capasso
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

5.  Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen.

Authors:  T P Pretlow; M A O'Riordan; K M Spancake; T G Pretlow
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

6.  Effect of dietary fat on colonic protein kinase C and induction of aberrant crypt foci.

Authors:  L M Lafave; P Kumarathasan; R P Bird
Journal:  Lipids       Date:  1994-10       Impact factor: 1.880

7.  Induction of colonic aberrant crypts in mice by feeding apparent N-nitroso compounds derived from hot dogs.

Authors:  Michael E Davis; Michal P Lisowyj; Lin Zhou; James L Wisecarver; James M Gulizia; Valerie K Shostrom; Nathalie Naud; Denis E Corpet; Sidney S Mirvish
Journal:  Nutr Cancer       Date:  2012-01-31       Impact factor: 2.900

8.  Association between factors associated with colorectal cancer and rectal aberrant crypt foci in humans.

Authors:  Akiko Ezuka; Eiji Sakai; Kenichi Kawana; Hajime Nagase; Yukio Kakuta; Shiori Uchiyama; Hidenori Ohkubo; Takuma Higurashi; Takashi Nonaka; Hiroki Endo; Hirokazu Takahashi; Atsushi Nakajima
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 9.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

Review 10.  Early detection of colon cancer: new tests on the horizon.

Authors:  Akshay K Gupta; Dean E Brenner; D Kim Turgeon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.